“…BALAD has been reported in various studies over the years, encompassing several case reports, case series, and retrospective studies spanning a spectrum of diseases, including toxoplasmosis chorioretinitis, [11] Vogt-Koyanagi-Harada disease, [12] neovascular macular degeneration, [13] acute idiopathic maculopathy, [14] central serious chorioretinopathy, [15] serpiginoid choroiditis, [16] blunt eye trauma with choroidal rupture, [17] posterior scleritis, [18] intraocular tuberculosis, [19] acute posterior multifocal placoid pigment epitheliopathy, [20] fungal endophthalmitis, [21] sympathetic ophthalmia, [22] and also DME. [23] In this retrospective study, we included treatment-naïve DME patients who received 3 monthly anti-vascular endothelial growth factor (anti-VEGF) injections and used SD-OCT to determine the prevalence and response to anti-VEGF treatment in eyes with DME either simultaneously presenting with or without BALAD.…”